Showing results (51-60 of 599) with videos related to
Sort By:
Pageof 60
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 18, 2012
Effects of pharmacokinetic processes and varied dosing schedules on the dynamics of acquired resistance to erlotinib in EGFR-mutant lung cancerJasmine Foo, Juliann Chmielecki, William Pao, et al.Trends in Genetics : TIG|February 21, 2012
Evolution of the cancer genomeOndrej Podlaha, Markus Riester, Subhajyoti De, et al.Plos Computational Biology|June 6, 2014
Histone modifications are associated with transcript isoform diversity in normal and cancer cellsOndrej Podlaha, Subhajyoti De, Mithat Gonen, et al.Plos One|July 21, 2017
Estimating mono- and bi-phasic regression parameters using a mixture piecewise linear Bayesian hierarchical modelRui Zhao, Paul Catalano, Victor G DeGruttola, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2013
Epidermal growth factor receptor tyrosine kinase inhibitor-resistant diseaseKadoaki Ohashi, Yosef E Maruvka, Franziska Michor, et al.Cancer Research|April 1, 2017
Mathematical Modeling Links Pregnancy-Associated Changes and Breast Cancer RiskDaniel Temko, Yu-Kang Cheng, Kornelia Polyak, et al.Journal of Theoretical Biology|October 26, 2005
Synergy and discounting of cooperation in social dilemmasChristoph Hauert, Franziska Michor, Martin A Nowak, et al.Plos One|November 5, 2015
Dose-Dependent Mutation Rates Determine Optimum Erlotinib Dosing Strategies for EGFR Mutant Non-Small Cell Lung Cancer PatientsLin L Liu, Fei Li, William Pao, et al.Seminars in Cancer Biology|August 2, 2005
Dynamics of colorectal cancerFranziska Michor, Yoh Iwasa, Christoph Lengauer, et al.Plos One|July 11, 2013
Stochastic Tunneling of Two Mutations in a Population of Cancer CellsHiroshi Haeno, Yosef E Maruvka, Yoh Iwasa, et al.Pageof 60